{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T20:23:52Z","timestamp":1750451032694},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1038\/sj.ijo.0801575","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T16:34:35Z","timestamp":1032453275000},"page":"478-485","source":"Crossref","is-referenced-by-count":8,"title":["Sibutramine metabolites increase glucose transport by cultured rat muscle cells"],"prefix":"10.1038","volume":"25","author":[{"given":"CJ","family":"Bailey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SL","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SH","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RB","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,4,20]]},"reference":[{"key":"BF0801575_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","volume":"12","author":"WR Buckett","year":"1988","unstructured":"Buckett WR, Thomas PC, Luscombe GP . The pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant which induces rapid noradrenergic down-regulation Prog Neuropsychopharmacol Biol Psychiat 1988 12: 575\u2013584.","journal-title":"Prog Neuropsychopharmacol Biol Psychiat"},{"key":"BF0801575_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0028-3908(89)90048-8","volume":"28","author":"GP Luscombe","year":"1989","unstructured":"Luscombe GP, Hopcroft RH, Thomas PC, Buckett WR . The contribution of metabolites to the rapid and potent down-regulation of rat cortical \u03b2-adrenoceptors by the putative antidepressant sibutramine hydrochloride Neuropharmacology 1989 28: 129\u2013134.","journal-title":"Neuropharmacology"},{"key":"BF0801575_CR3","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","volume":"126","author":"IP Connoley","year":"1999","unstructured":"Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ . Thermogenic effects of sibutramine and its metabolites Br J Pharmac 1999 126: 1487\u20131495.","journal-title":"Br J Pharmac"},{"key":"BF0801575_CR4","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","volume":"121","author":"HC Jackson","year":"1997","unstructured":"Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ . Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline re-uptake inhibitor, sibutramine, in the rat Br J Pharmac 1997 121: 1613\u20131618.","journal-title":"Br J Pharmac"},{"key":"BF0801575_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.ijo.0800636","volume":"22","author":"C Day","year":"1998","unstructured":"Day C, Bailey CJ . Effect of the antiobesity agent sibutramine in obese-diabetic ob\/ob mice Int J Obes Relat Metab Disord 1998 22: 619\u2013623.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801575_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","volume":"56","author":"W McNeely","year":"1998","unstructured":"McNeely W, Gor KL . Sibutramine: a review of its contribution to the management of obesity Drugs 1998 56: 1093\u20131124.","journal-title":"Drugs"},{"key":"BF0801575_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/clpt.1991.144","volume":"50","author":"M Weintraub","year":"1991","unstructured":"Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML . Sibutramine in weight control: a dose-ranging efficacy study Clin Pharmac Ther 1991 50: 330\u2013337.","journal-title":"Clin Pharmac Ther"},{"key":"BF0801575_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","volume":"106","author":"M Apfelbaum","year":"1999","unstructured":"Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E . Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine Am J Med 1999 106: 179\u2013184.","journal-title":"Am J Med"},{"key":"BF0801575_CR9","first-page":"188","volume":"53","author":"R Vargas","year":"1994","unstructured":"Vargas R, McMahan FG, Jain AK . Effects of sibutramine versus placebo in NIDDM Clin Pharmac Ther 1994 53: 188.","journal-title":"Clin Pharmac Ther"},{"issue":"Suppl 2","key":"BF0801575_CR10","first-page":"41","volume":"19","author":"J Griffiths","year":"1995","unstructured":"Griffiths J, Brynes AE, Frost G, Bloom SR, Finer N, Jones SP, Romanec FM . Sibutramine in the treatment of overweight non-insulin dependent diabetics Int J Obes Relat Metab Disord 1995 19 (Suppl 2): 41.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801575_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1073\/pnas.61.2.477","volume":"61","author":"D Yaffe","year":"1968","unstructured":"Yaffe D . Retention of differentiation potentialities during prolonged cultivation of myogenic cells Proc Natl Acad Sci USA 1968 61: 477\u2013483.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF0801575_CR12","first-page":"61","volume":"222","author":"DT Wong","year":"1982","unstructured":"Wong DT, Threlkeld PG, Best KL, Bymaster FP . A new inhibitor of norpinepnrine uptake devoid of affinity for receptors in rat brain J Pharm Exp Ther 1982 222: 61\u201365.","journal-title":"J Pharm Exp Ther"},{"key":"BF0801575_CR13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/0006-2952(83)90284-8","volume":"32","author":"DT Wong","year":"1983","unstructured":"Wong DT, Bymaster FP, Reid LR . Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors Biochem Pharmac 1983 32: 1287\u20131293.","journal-title":"Biochem Pharmac"},{"issue":"Suppl 1","key":"BF0801575_CR14","first-page":"S18","volume":"22","author":"DJ Heal","year":"1998","unstructured":"Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC . Sibutramine: a novel antiobesity drug Int J Obes Relat Metab Disord 1998 22 (Suppl 1): S18\u2013S28.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801575_CR15","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0026-0495(78)80007-9","volume":"27","author":"CR Kahn","year":"1978","unstructured":"Kahn CR . Insulin resistance, insulin insensitivity and insulin unresponsiveness: a necessary distinction Metabolism 1978 27: 1893\u20131902.","journal-title":"Metabolism"},{"key":"BF0801575_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s001250050780","volume":"40","author":"GD Holman","year":"1997","unstructured":"Holman GD, Kasuga M . From receptor to transporter: insulin signalling to glucose transport Diabetologia 1997 40: 991\u20131003.","journal-title":"Diabetologia"},{"key":"BF0801575_CR17","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","volume":"269","author":"CJ Vlahos","year":"1994","unstructured":"Vlahos CJ, Matter WJ, Hui KY, Brown RF . A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl-8-phenyl)-4H-1-benzopyran-4-one (LY294002) J Biol Chem 1994 269: 5241\u20135248.","journal-title":"J Biol Chem"},{"key":"BF0801575_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2337\/diacare.13.3.228","volume":"13","author":"A Klip","year":"1990","unstructured":"Klip A, Paquet M . Glucose transport and glucose transporters in muscle and their metabolic regulation Diabetes Care 1990 13: 228\u2013243.","journal-title":"Diabetes Care"},{"key":"BF0801575_CR19","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/S0021-9258(18)52289-4","volume":"266","author":"UM Koivisto","year":"1991","unstructured":"Koivisto UM, Martinez-Valdez H, Bilan PJ, Burkett E, Ramlal T, Klip A . Differential regulation of GLUT1 and GLUT4 glucose transport systems by glucose and insulin in L6 muscle cells in culture J Biol Chem 1991 266: 2615\u20132621.","journal-title":"J Biol Chem"},{"key":"BF0801575_CR20","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0021-9258(19)40047-1","volume":"265","author":"PS Walker","year":"1990","unstructured":"Walker PS, Ramlal T, Sarabia V, Koivisto UM, Bilan PJ, Pessin JE, Klip A . Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription J Biol Chem 1990 265: 1516\u20131523.","journal-title":"J Biol Chem"},{"key":"BF0801575_CR21","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1210\/endo.130.5.1572281","volume":"130","author":"A Klip","year":"1992","unstructured":"Klip A, Guma A, Ramlel T, Bilan PJ, Lam L, Leiter LA . Stimulation of hexose transport by metformin in L6 muscle cells in culture Endocrinology 1992 130: 2535\u20132544.","journal-title":"Endocrinology"},{"key":"BF0801575_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.2337\/diab.35.9.990","volume":"35","author":"RR Henry","year":"1986","unstructured":"Henry RR, Wallace P, Olefsky JM . Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin dependent diabetes mellitus Diabetes 1986 35: 990\u2013998.","journal-title":"Diabetes"},{"key":"BF0801575_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/archinte.1987.00370100063012","volume":"147","author":"RR Wing","year":"1990","unstructured":"Wing RR, Shoemaker M, Marcus MDM, McDermott M, Gooding W . Variables associated with weight loss and improvements in glycemic control in type 2 diabetic patients Arch Intern Med 1990 147: 1749\u20131753.","journal-title":"Arch Intern Med"},{"key":"BF0801575_CR24","first-page":"E769","volume":"255","author":"AD Baron","year":"1988","unstructured":"Baron AD, Brechtel G, Wallace P, Edelman SV . Rates and tissue sites of non-insulin and insulin-mediated uptake in humans Am J Physiol 1988 255: E769\u2013E774.","journal-title":"Am J Physiol"},{"key":"BF0801575_CR25","first-page":"177","volume":"5","author":"RA DeFronzo","year":"1997","unstructured":"DeFronzo RA . Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes Diabetes Rev 1997 5: 177\u2013269.","journal-title":"Diabetes Rev"},{"key":"BF0801575_CR26","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","volume":"121","author":"HC Jackson","year":"1997","unstructured":"Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ . Comparison of the effect of sibutramine and other monoamine reuptake inhibitors on food intake in the rat Brit J Pharmac 1997 121: 1758\u20131762.","journal-title":"Brit J Pharmac"},{"key":"BF0801575_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","volume":"25","author":"DJ Heal","year":"1998","unstructured":"Heal DJ, Cheetham SC, Prow MR, Martin KF, Buckett WR . A comparison of the effects on central 5HT function of sibutramine hydrochloride and other weight-modifying agents Br J Pharmac 1998 25: 301\u2013308.","journal-title":"Br J Pharmac"},{"key":"BF0801575_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1463-1326.1999.00037.x","volume":"1","author":"MJ Bickerdike","year":"1999","unstructured":"Bickerdike MJ, Vickers SP, Dourish CT . 5-HT2c receptor modulation and the treatment of obesity Diabetes Obes Metab 1999 1: 207\u2013214.","journal-title":"Diabetes Obes Metab"},{"key":"BF0801575_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2337\/diacare.12.4.252","volume":"12","author":"RG Pestell","year":"1989","unstructured":"Pestell RG, Crock PA, Ward GM, Alford FP, Best JD . Fenfluramine increases insulin action in patients with NIDDM Diabetes Care 1989 12: 252\u2013258.","journal-title":"Diabetes Care"},{"key":"BF0801575_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2337\/diacare.14.4.325","volume":"14","author":"AJ Scheen","year":"1991","unstructured":"Scheen AJ, Paolisso G, Salvatore T, Lefebvre PJ . Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine Diabetes Care 1991 14: 325\u2013332.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"BF0801575_CR31","first-page":"73","volume":"5","author":"MJ Kirby","year":"1975","unstructured":"Kirby MJ, Turner P . Fenfluramine and nor-fenfluramine on glucose uptake into skeletal muscle Postgrad Med J 1975 5 (Suppl 1): 73\u201376.","journal-title":"Postgrad Med J"},{"key":"BF0801575_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0006-2952(90)90215-7","volume":"39","author":"S Sasson","year":"1990","unstructured":"Sasson S, Kunievsky B, Nathan C, Cerasi E . On the role of 5-hydroxytrytamine in the peripheral action of fenfluramine: studies with the isolated rat soleus muscle Biochem Pharmac 1990 39: 965\u2013968.","journal-title":"Biochem Pharmac"},{"key":"BF0801575_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W","volume":"38","author":"HL Rowley","year":"2000","unstructured":"Rowley HL, Bulter SA, Prow MR, Aspley S, Kilpatrick IC, Heal DJ . A comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely-moving rats Synapse 2000 38: 167\u2013176.","journal-title":"Synapse"},{"key":"BF0801575_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00060793-199702000-00005","volume":"4","author":"L Kosmiski","year":"1997","unstructured":"Kosmiski L, Eckel RH . Anorectic agents in non-insulin dependent diabetes mellitus Cur Opin Endocrinol Diabetes 1997 4: 36\u201339.","journal-title":"Cur Opin Endocrinol Diabetes"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0801575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801575","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:17:10Z","timestamp":1684221430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0801575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["BF0801575"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0801575","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}